Ontology highlight
ABSTRACT:
SUBMITTER: Sawaki A
PROVIDER: S-EPMC5906488 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
Sawaki Akira A Yamada Yasuhide Y Yamaguchi Kensei K Nishina Tomohiro T Doi Toshihiko T Satoh Taroh T Chin Keisho K Boku Narikazu N Omuro Yasushi Y Komatsu Yoshito Y Hamamoto Yasuo Y Koizumi Wasaburo W Saji Shigehira S Shah Manish A MA Van Cutsem Eric E Kang Yoon-Koo YK Iwasaki Junko J Kuriki Hiroshi H Ohtsuka Wataru W Ohtsu Atsushi A
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20171020 3
<h4>Background</h4>AVAGAST was an international, randomized, placebo-controlled phase III study of chemotherapy with or without bevacizumab as first-line therapy for patients with advanced gastric cancer. We performed exploratory analyses to evaluate regional differences observed in the trial.<h4>Methods</h4>Analyses were performed in the placebo plus chemotherapy arm (intention-to-treat population). Chemotherapy was cisplatin 80 mg/m<sup>2</sup> for six cycles plus capecitabine (1000 mg/m<sup>2 ...[more]